机构:[1]Laboratory of Pathology, Hebei Cancer Institute, The Fourth Hospital of Hebei Medical University, Jiankang Road 12, Shijiazhuang 050011, Hebei, China临床科室河北省肿瘤研究所河北医科大学第四医院
This study was supported by Grants from the National Natural
Science Foundation of China (No. 81772612), Natural Science Foundation
of Hebei Province (No. H2020206363).
第一作者机构:[1]Laboratory of Pathology, Hebei Cancer Institute, The Fourth Hospital of Hebei Medical University, Jiankang Road 12, Shijiazhuang 050011, Hebei, China
共同第一作者:
通讯作者:
通讯机构:[1]Laboratory of Pathology, Hebei Cancer Institute, The Fourth Hospital of Hebei Medical University, Jiankang Road 12, Shijiazhuang 050011, Hebei, China
推荐引用方式(GB/T 7714):
Dong Zhiming,Yang Liu,Lu Juntao,et al.Downregulation of LINC00886 facilitates epithelial-mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma.[J].CLINICAL & EXPERIMENTAL METASTASIS.2022,39(4):661-677.doi:10.1007/s10585-022-10171-w.
APA:
Dong Zhiming,Yang Liu,Lu Juntao,Guo Yanli,Shen Supeng...&Guo Wei.(2022).Downregulation of LINC00886 facilitates epithelial-mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma..CLINICAL & EXPERIMENTAL METASTASIS,39,(4)
MLA:
Dong Zhiming,et al."Downregulation of LINC00886 facilitates epithelial-mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma.".CLINICAL & EXPERIMENTAL METASTASIS 39..4(2022):661-677